This Week’s Life Science Headlines

        Litigation
Continue reading...

Court Rejects Misrepresentation Claim Against Manufacturer For Ingestion of Others’ Generic Drugs

On July 29, the district court in the Eastern District of Kentucky dismissed several claims against Eli Lilly and Company (Lilly) in which the plaintiffs admitted that they could not prove that they ingested any product manufactured, sold, or distributed by Lilly. A copy of the opinion can be found here. This Multi-District Litigation relates to Darvocet, Darvon, and propoxyphene products, pain medications that the FDA stated in 2009 were linked to “fatal overdoses.” In these particular cases, the plaintiffs conceded that they had…
Continue reading...